AI assistant
Sending…
Luye Pharma Group Limited — Earnings Release 2006
Jul 27, 2006
50431_rns_2006-07-27_a4c9256a-9772-4757-b09d-6e75305e95d9.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
| Listed Company Information |
| TAKSON HOLDINGS<00918> - Results Announcement Takson Holdings Limited announced on 27/07/2006: (stock code: 00918 ) Year end date: 31/03/2006 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/04/2005 from 01/04/2004 to 31/03/2006 to 31/03/2005 Note ('000 ) ('000 ) Turnover : 135,278 110,608 Profit/(Loss) from Operations : (19,676) 15,465 Finance cost : (4,487) (2,707) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : (20,454) 11,424 % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.0446) 0.0293 -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (20,454) 11,424 Final Dividend : N/A N/A per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : N/A Payable Date : N/A B/C Dates for Annual General Meeting : 23/08/2006 to 25/08/2006 bdi. Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: (Loss) / earning per share The calculation of basic (loss) / earning per share is based on the Group's Loss attributable to equity holders of HK$20,454,000. (2005 restated: HK$11,424,000) (Loss) / basic earning per share is calculated by the weighted average number of 459,086,000 ordinary shares (2005:389,500,000) in issue during the year. No diluted earnings per share is presented as there is no dilutive potential ordinary share for the years ended 31st March 2006 and 2005. |
More from Luye Pharma Group Limited
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 29
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Earnings Release
2026
Mar 31